Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank44
3Y CAGR-1.2%
5Y CAGR-9.1%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-1.2%/yr
Annual compound
5Y CAGR
-9.1%/yr
Recent acceleration
Percentile
P44
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.01 | -26.7% |
| 2024 | 0.02 | -27.1% |
| 2023 | 0.02 | +80.9% |
| 2022 | 0.01 | -50.5% |
| 2021 | 0.03 | +30.0% |
| 2020 | 0.02 | +91.8% |
| 2019 | 0.01 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |